Rx for Biotech

By: Podcast Host Chris Leidli
Listen for free

  • Summary

  • The Rx for Biotech podcast is focused on the promise of advanced therapies and the leaders across the ecosystem bringing these innovative medicines to patients in need. The podcast features interviews with the experts and industry leaders developing advanced therapies and enabling technologies including physicians, healthcare providers, patient advocates, and biopharma leaders.
    All rights reserved
    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2
Episodes
  • Unlocking the Power of IL-2 with Aulos CEO, Aron Knickerbocker

    Unlocking the Power of IL-2 with Aulos CEO, Aron Knickerbocker
    Sep 18 2024
    Immunotherapies continue to redefine treatment for many types of cancer and one of the first immunotherapies approved and used clinically as a therapeutic is Interleukin-2, or IL-2. Aulos Bioscience is an immuno-oncology company that has developed AU-007, a potential best-in-class IL-2, that improves on many of the other IL-2 products in development. In this episode, we discuss the promise of AU-007 with President and CEO, Aron Knickerbocker. Link to Interleukin-2 review article can be found here: https://www.nature.com/articles/s41587-022-01390-3
    Show more Show less
    38 mins
  • Left Behind: Addressing Health Equity for the Rare Disease Patient Community

    Left Behind: Addressing Health Equity for the Rare Disease Patient Community
    Sep 9 2024
    In this podcast episode, we discuss the importance of addressing health equity for the rare disease community with Tamar Thompson, Head of Corporate Affairs at Alexion, AstraZeneca Rare Disease. Tamar discussed her efforts to champion health policy, advocacy, equity, and awareness for rare diseases. Link to NMOSD video mentioned in episode: https://www.youtube.com/playlist?list=PLJQx_6LtucSB9GGeiWTycLm7wjK_LX0ZI
    Show more Show less
    21 mins
  • Emerging Cell Therapies for Blood Cancers with Arcellx CMO, Chris Heery, MD

    Emerging Cell Therapies for Blood Cancers with Arcellx CMO, Chris Heery, MD
    Sep 5 2024
    In this podcast episode, we sit down with Christopher Heery, the Chief Medical Officer at Arcellx to learn about the company's pipeline and lead cell therapy, anitocabtagene autoleucel, or anito-cel, that is in development for multiple myeloma. Multiple myeloma, like lymphoma and leukemia are types of cancer that start in your blood cells.
    Show more Show less
    30 mins
Economics
Show more Show less

What listeners say about Rx for Biotech

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available